Corporate ESG Performance and Audit Fees: Evidence from Chinese A-Share Listed Companies
Exploring Science Academic Conference Series · 17.03.2026 · 13 · 118-131
DOI: 10.70267/icbms.2601.118131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploring Science Academic Conference Series, online erschienen am 17.03.2026. Verfasst von Yaofei Zhu. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Corporate ESG performance has emerged as a core indicator for evaluating a firm's sustainability and risk profile. Given the growing emphasis on risk-based approaches to audit pricing, how auditors assess the risks associated with corporate ESG performance remains a critical issue that warrants in-depth exploration. This study reveals that superior corporate ESG performance is significantly associated with lower audit fees. Mechanism tests show that strong ESG performance effectively mitigates corporate operating risk. This mitigation significantly reduces the audit risks perceived by auditors, which in turn optimizes audit procedures and ultimately lowers audit fees. Heterogeneity analysis reveals that this negative relationship is more pronounced in firms audited by non-Big Four accounting firms and those that do not hold shares in financial institutions. This study provides novel empirical evidence for audit pricing mechanisms from an ESG perspective and enriches the existing literature on the economic consequences of corporate ESG performance.
Zitieren
APA
Zhu, Y. (2026). Corporate ESG Performance and Audit Fees: Evidence from Chinese A-Share Listed Companies. Exploring Science Academic Conference Series, 13, 118-131. https://doi.org/10.70267/icbms.2601.118131
Vancouver
Zhu Y. Corporate ESG Performance and Audit Fees: Evidence from Chinese A-Share Listed Companies. Exploring Science Academic Conference Series. 2026;13:118-131. doi:10.70267/icbms.2601.118131
BibTeX
@article{Zhu2026,
author = {Zhu, Yaofei},
title = {Corporate ESG Performance and Audit Fees: Evidence from Chinese A-Share Listed Companies},
journal = {Exploring Science Academic Conference Series},
year = {2026},
volume = {13},
pages = {118--131},
doi = {10.70267/icbms.2601.118131}
}
EUVIMED